Skip to main content
Clinical Trials/NL-OMON47656
NL-OMON47656
Completed
N/A

Robot-assisted gait training and assessment for neurological patients - Robot-assisted gait training and assessment

niversiteit Twente0 sites130 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversiteit Twente
Enrollment
130
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversiteit Twente

Eligibility Criteria

Inclusion Criteria

  • In general the inclusion criteria for healthy subjects and SCI/stroke subjects are:
  • \-age \> 18 years
  • \- a stable medical condition
  • \- a physical condition which allows for 3 minutes of supported walking
  • \- have sufficient cognitive abilities (Mini\-Mental State Examination \* 22\) ;Specifically inclusion criteria for spinal cord injury patients are:
  • \- a first ever SCI
  • \- time since injury \> 6 months
  • \- complete or incomplete lesion (AIS A,B, C or D)
  • \- injury to the spinal cord from below C6, on at least one side of the body
  • \- able to sit unsupported (to sit upright without using the hands or an external support) ;Stroke patients are explicitly included in the study if they:

Exclusion Criteria

  • Healthy subjects, spinal cord injury patients and stroke patients are excluded if they:
  • \- have current orthopaedic problems
  • \- other neurological diseases
  • \- have a history of cardiac conditions that interfere with physical load
  • \- had no independent ambulation prior to SCI or stroke,
  • \- have contraindication for lower extremity weight bearing (chronic joint pain, fracture)
  • \- inappropriate or unsafe fit of the robotic trainer due to the participant\*s body size (bodyweight \> 100 kg) and/ or joint contractures.
  • \- have spin\-stabilizing devices for whom their treating surgeon contraindicates gait
  • \- have pressure sore stage 2 or higher

Outcomes

Primary Outcomes

Not specified

Similar Trials